Trial · NCT07887620
Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic Counseling
NCT07887620, Not applicable, Recruiting, Roswell Park Cancer Institute
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic Counseling. Trials, record NCT07887620. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887620
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Chatbot Utilization for Pedigree Creation and Cancer Risk Assessment in Cancer Genetic Counseling
- NCT number
- NCT07887620
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 129 participants, estimated
- Lead sponsor
- Roswell Park Cancer Institute
- Conditions
- Hereditary Breast Carcinoma, Hereditary Malignant Neoplasm
- Interventions
- Text Message -based Navigation Intervenion, Artificial Intelligence based Intervention
- First posted
- 2026-10-21
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sensitivity and specificity of chatbot in determining if patient meets National Comprehensive Cancer Network (NCCN) criteria for germline genetic testing | Up to 21 days before genetics appointment | Will assess the sensitivity of a chatbot in determining if a patient meets NCCN criteria for germline genetic testing compared to the gold standard of a certified genetic counselor's (CGC's) determination |
| Secondary | Accuracy of chatbot generated family history pedigree | Up to 21 days before genetics appointment | Graded by a CGC on a five point scale with 1 = entirely unreliable to 5 = no clinically meaning full errors. |
| Secondary | chatbot generated Tyrer Cuzick determination of breast cancer risk | Up to 21 days before genetics appointment | To assess chatbot's determination of whether patient's lifetime breast cancer risk is estimated at greater than 20% utilizing the Tyrer-Cuzick algorithm |
| Secondary | Proportion of patients with greater than 20% lifetime breast cancer risk | Up to 21 days before genetics appointment | Assessed by the Tyrer-Cuzick model |
| Secondary | Patient satisfaction survey with using a chatbot | Up to 7 days after genetics appointment | Self administered Patient survey assessing satisfaction of using chatbot with responses ranging from strongly agree to Strongly disagree |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887620
GET https://conductscience.org/api/trials/v1/NCT07887620/registered